drugset / Trial / NCT06055348
SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A phase Ib/II clinical study on the safety, pharmacokinetic characteristics, and preliminary efficacy of SC0191 combination chemotherapy in patients with advanced ovarian cancer.
Timeline
- Start
- 2023-10-30
- Primary completion
- 2025-08-30
- Completion
- 2025-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |
| Subject | SC0191 | Small molecule | — | Oral |